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Abstract
Objective: Personal Digital Assistants (PDAs) have the potential to improve clinical trial data collection; however, most 
current PDA-based clinical data collection systems typically collect and store data in the offline mode, and then transfer the 
data to an operational database. The purpose of this study was to explore the usefulness of a wireless clinical data collection 
system for an irritable bowel syndrome trial compared with the traditional paper based data collection. Methods: We have 
developed a PDA-based data capture system for clinical trials, and tested it in a double-blind trial. Sixty four patients with 
irritable bowel syndrome were randomly selected and divided into a control group that used the standard paper report forms 
(CRF) and an intervention group that used the electronic report forms (e-CRF), daily for five weeks. There were 630 data 
sets consisting of six questions each, and thus 3,570 data points total were collected. Results: The response rate of the 
control group was significantly higher than that of the intervention group. However, the completeness of the response in the 
intervention group was higher and the number of input errors per person for the PDA group was lower than in the paper 
group. Conclusion: A PDA based electronic diary improved the response rate and decreased input errors in an IBS trial. We 
conclude that mobile devices can be very useful, especially when the proposed design and connectivity aspects have been 
taken into account. (Journal of Korean Society of Medical Informatics 15-2, 235-244, 2009)
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I. Introduction
Clinical trials are the most expensive and time con-
suming steps in drug development. In a paper-based cli-
nical trial process, a Case Report Form (CRF), which is 
data collection form, typically has three or four copies 
per page, and the monitoring is typically done by hand 
at the investigative site comparing the CRF with source 
documents. The CRF data are later entered twice at a 
central location into a database. Information technology 
has been used to support clinical trials to have the most 
immediate and noticeable impact on drug development. 
Clinical trial technology that has been applied to 
improve clinical trial data collections is generally re-
ferred to as electronic data capture (EDC). The benefits 
of EDC include direct data entry at the investigator site 
leading to greater accuracy, fewer queries, decreased 
paper record storage, and timelier population of the 
study database1). Although increasing in pace, the con-
version to EDC has been a slow progression2). A survey 
conducted in the year 2001 reported that only 5 percent 
of all new clinical trials made use of remote data entry 
for clinical trials, whereas the remaining 95 percent 
continued to use paper3). 
The internet allows transfer of clinical trial infor-
mation and coordination of multiple clinical trial pro-
cesses. Therefore, the Internet have increasingly been 
utilized in clinical trials4)5). However, wired internet 
needs to connect the computer to the location where the 
Internet connection is available. Recently, mobile com-
puting technology is proposed to improve information 
access, enhance workflow, and promote evidence-based 
practice to make informed and effective decisions at 
any place and any time. Mobile devices have been used 
in clinical trials for more than 16 years, utilizing dif-
ferent technologies. These devices have been used in 
different medical fields such as diabetes6)7), nutrition8), 
different surveys9). The mobile technology capable of 
data capture or data entry becomes employed in clinical 
trials. The variety of applications in clinical trials ranges 
from electronic patient diaries10-12) to electronic case 
report forms (eCRFs)13)14). 
Personal Digital Assistants (PDAs) are one the most 
popular mobile devices embedding mobile internet com-
munication network. The PDAs offer portable and uno-
btrusive access to clinical data and relevant information 
at the point of care. They have been extensively tested 
and have shown mixed results as a data collection tool 
by physician users15)16) and patient users17) based on the 
application. The main advantage of PDA is to link a 
PDA to a central computer anytime and anyplace, 
whereas the wired systems are strained to the location 
where the connection exists. It enables to centralize 
study information and coordinate multiple trial processes 
in real time at a lower cost18). In Korea, mobile internet 
subscribers exceeded 30 million, about 70% of the 
population by 200219). The mobile internet is generally 
used data communication network for everyday life 
such as mobile shopping, mobile banking, and mobile 
advertising in Korea. In spite of spreading mobile tech-
nology in Korea, data collection in clinical trial studies 
has still done on paper first and sometimes with elec-
tronic data entry taking place later. Furthermore, even 
few PDA-based clinical data collection systems typically 
collect and store data in offline mode, and then syn-
chronize with the server by transferring to the opera-
tional database. Also, data review, data quality checks, 
and monitoring were performed manually and locally at 
the site. Real time data collection and transmit through 
mobile internet connection is still challenging area.
In response to these challenges, we have developed a 
wireless PDA application that patients can use both to 
evaluate their experience with a drug and to directly 
transmit their data to a database using a wireless in-
ternet connection. We used PDA instead of paper pa-
tient diaries in a randomized, placebo-controlled, double- 
blind irritable bowel syndrome (IBS) trial. IBS, a func-
tional gastrointestinal disorder, rely exclusively on pa-
tients’ self reports of their symptoms20).
The purpose of this study is to determine the im-
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Figure 1. Study design for paper and PDA
No Category Measurementfrequency Question items Severity
1 Abdominal discomfort
 or abdominal pain
Daily How severe do you feel abdominal discomfort or 
  abdominal pain today?
0=None
1=Mild
2=Moderate 
3=Severe
2 Abdominal distension Daily How severe do you feel abdominal distension today? 0=None
1=Mild
2=Moderate 
3=Severe
3 Defecation Daily Did you defecate today? 0=No
1=Yes
5 Stool frequency Daily How frequently do you defecate? 0=None
1=One 
2=Two 
3=More than 3 times 
4 Hard or lumpy stools Daily Do you feel hard or lumpy stools after defecating?
Do you feel incomplete rectal evacuation after a bowel 
  movement? 
Do you feel defecation frequently?
0=No 
1=Yes
6 Stool form Daily How would you describe your stools? 0=Hard
1=Solid 
2=Watery
Table 1. Question items for the study
provement of speed, data accuracy and protocol com-
pliance of PDA clinical data collection system com-
paring with traditional paper based data collection, 
which is popular way of current study, in the irritable 
bowel syndrome clinical trials study. 
II. Materials and Methods
A randomized double-blind study was carried out to 
verify whether Remeron compared to placebo relieves 
irritable bowel syndrome (IBS). The study was ap-
proved by the Institutional Review Board of the hos-
pital, and was designed as a double-blind clinical trial 
for efficacy of Remeron for IBS patients. Initially, 
sixty-four IBS patients from an 800-bed hospital signed 
informed consent forms. Subjects were required to visit 
one week before treatment for screening, to determine 
whether they met the inclusion criteria. Subjects took 
the actual medication or the placebo medication for four 
weeks and submitted a questionnaire each week. Pa-
tients visited the site each week during the one week of 
screening period and at weeks 2, 3, 4, 5, and 6 of the 
treatment period (Fig. 1). The study was conducted 
from Nov. 2001 to Apr. 2003.
The sixty four patients, who agreed to participate in 
the IBS clinical trial for the Remeron, were self-selected 
to either the experimental (PDA data entry) group or 
the control (standard paper data entry) group, according 
to their preference. Subjects of both control group and 
intervention group are asked to complete the question-
naires consisting of 6 check lists everyday as suggested 
in Table 1. 
Research coordinators gained the informed consent 
and enter patients’ basic information into the system at 
the beginning. Both forms are completed once daily at 
home for five weeks. 
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Figure 2. Data flow for PDA clinical data collection system
* DB: Database 
†  MHS: Message handling system 
‡ ASP: Active server page
The eighteen subjects in the control group are re-
quested to fill in the questionnaires daily on the paper 
CRFs for one week and bring the completed papers to 
next planned visit. 
On the other hand, the eighteen subjects in the 
intervention group are requested to answer question-
naires on the PDA till two o’clock of the next day of 
taking medication everyday and transmit data to the 
server through wireless internet. 
This result in 630 data sets consisting of six que-
stionnaires each, and 3,570 data points total. The inter-
vention group subjects complete the six items on the 
PDA and transfer the complete data it by two o’clock 
each day using wireless internet. The control group 
subjects were asked to fill out the paper daily, and 
submit seven paper CRFs each week at their planned 
visits. Then, a coordinator entered their data into a web 
application later. 
Measurement instruments for the effectiveness of the 
PDAs in collecting clinical trial data were developed in 
consultation with the co-authors of clinical side,: a) 
response rate; b) completeness of data; c) the number of 
input errors; and d) protocol compliance. Response rate 
measured the extent to which they used the e-CRFs 
during the treatment period. Response completeness was 
measured whether the subjects answered all data items 
completely. Matthew et al. also proposed completeness 
of data to evaluate data quality for PDA data collec-
tion21). A chi-square test was conducted to compare 
response rates and response completeness between the 
two groups. Additionally, the Mantel-Haenszel chi- 
square test was applied to identify the influence of data 
collection methods on response completeness controlling 
demographic variables. Finally, the number of input 
errors and protocol compliance were measured.
 Protocol compliance means that both groups should 
enter their medication intakes during five weeks at five 
measurement periods on a paper or a PDA form. 
Subjects usually report that they fill out the survey form 
following the protocol. However, subjects usually forget 
to write down the form at the exact time. This study 
compared the reported compliance and actual 
compliance. 
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Figure 3. Log-in screen and que-
stionnaire screen for 
PDA
Reason Withdrawals 
Improved health condition  2
Study protocol violation  3
Fail to track patients 13
Administrative problems  5
Past disease history  5
Total 28
Table 2. Reason for withdrawal of participants
1. System architecture
Our data collection system is comprised of two 
components: a) a web application for internal users and 
subjects; and b) PDA application composed of an admi-
nistrator module and a subject module Web application 
(Fig. 2).
The web application was developed with Active 
Server Page (ASP) and Javascript. MS SQL Server was 
used as database. The web application was divided by 
two parts by the types of users: such as administrators 
or coordinators, and subjects. Application for internal 
users has Active Sync 3.1 program to synchronize the 
PDA application with the desktop application. 
Authenticated users can then update and edit data 
through any web browser, which permits a reliable and 
wireless internet access. 
Coordinators can enroll eligible subjects and check 
the entered data, add new subjects, modify and review 
information for registered subjects, and review the status 
of the current study. They are also able to enter and 
revise demographic information and make inquiries 
about all entered information through PDAs or desktop. 
Administrators are able to enter and manage patient 
information and assign appropriate privilege to study 
personnel, thus allowing management of subjects and 
information. They can also check for redundant identi-
fication when new subjects are added. By clicking the 
detail button on the subject list, a graph and table with 
data analysis pop up on the screen.
The Cesscon LUXian 2500 model of PDAs, installing 
Microsoft CE operating systems, are distributed to 
eligible subjects at free of charge. Subjects can gain 
access into the PDA CDCS through the phone number 
assigned by the wireless provider and enter the IP 
address of the gateway server. PDA software allows for 
only a single patient’s data to be collected at any one 
time. Once the PDA has been synchronized with the 
personal computer, the patient self-reported data are 
purged from the unit. These features ensure that only 
the current user’s data are stored on the PDA and that 
the data are only accessible to the coordinators and 
monitors. 
The electronic case report form for PDA was de-
signed for this study as Figure 3. The subjects are 
requested to enter their data everyday about perceived 
changes in their specific symptoms from 12 till at least 
2 o’clock during the treatment period as shown in 
Figure 1. Once they complete answers, and then send 
data into the central server through mobile internet 
connection. Figure 3 shows the log-in screen and input 
Wireless Clinical Trial of Data Capture using a Personal Digital Assistant
240
Variables Control Intervention χ2 p
Sex Male (N=19)  8 (44%) 11 (61%) 1.01 0.3166
Female (N=17) 10 (56%)  7 (39%)
Age (Average) 52.5±12.3 35.6±10.4 4.46 0.0001
Disease duration 4.1±3.3 6.2±9.4 0.90 0.3782
Table 3. Demographic characteristics of patients
Response Control (N=630)*
Intervention 
(N=630)* χ
2 p
Yes 595 (94.4%) 487 (77.3%) 76.31 0.0001
No  35 ( 5.6%) 143 (22.7%) 76.31 0.0001
* 18 subjects×35 days (5 wks)
Table 4. Response rate                                           Unit : N (%)
Conpleteness Control(N=3,570)*
Intervention
(N=2,922)† χ
2 p
Complete 3,409 (95.5%) 2,894 (99.0%) 71.71 0.0001
Incomplete  161 ( 4.5%)   28 ( 1.0%) 71.71 0.0001
* 595 response×6 items
† 487 response×6 items
Table 5. Response completeness                           Unit : N (%)
screen for the PDA application.
III. Results
Sixty four patients initially enrolled to participate, but 
twenty eight patients withdrew for the following reasons 
suggested by Table 2.
1. Demographic characteristics 
The sample for this study consisted of 18 patients 
(50%) for control and 18 patients (50%) for inter-
vention; 19 (53%) were women, and 17 (47%) were 
men. The mean age for the control group ranged from 
52.5 +/− 12.3 and 35.6 +/− 10.4 for the intervention 
group. 
The demographic characteristics of the participants 
are summarized in Table 1. The two groups did not 
have any significant demographic differences, except 
age. Age between the two groups shows statistically 
significant difference. The age of the control group was 
much higher than the intervention group (p<0.0001). 
These significant age differences can make selection 
bias. To control selection bias, patients in the common 
age range should be retested. The common age range is 
40 to 45 years. However, there are only four patients in 
the intervention group and five patients in the control 
group within this age range. Thus, additional analysis 
cannot be conducted because the sample size is too 
small. And, disease duration of control group and inter-
vention group is 4.1 and 6.2 year respectively. How-
ever, it doesn’t show statistical difference (Table 3).
2. Response rate
Both groups need to submit results for five weeks, 
totaling 630 submissions per group. Out of 630 ex-
pected submissions, the response rate for the control 
group was 94.4 percent (595 submissions), whereas the 
e-CRF response rate for the intervention group was 77.3 
percent (487 submissions). Thus, the response rate for 
the control group was higher than that for the inter-
vention group (p<0.0001) (Table 4)
3. Response completeness
Response completeness measures whether or not pa-
tients submitted complete data elements on paper CRFs 
or e-CRFs. Since 595 CRF from the control group are 
submitted, the 3,570 items are supposed to be com-
pleted. Out of 3,570 items on paper CRFs, 3,409 items 
are complete and 161 items are incomplete. By contrast, 
out of 2,922 items, the patients of the intervention 
group are supposed to submit, 2894 items are complete 
and 28 items are incomplete data items. Thus, the res-
ponse completeness of the intervention group is higher 
than that of the control group (p<0.0001) (Table 5).
A Mantel-Haenszel chi square test was performed to 
identify the influence of data collection methods on res-
ponse completeness controlling demographic variables. 
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Control Intervention
1-2 weeks (N=252)
 Complete (case) 240 212
 Incomplete (case)  12  40
   Reported compliance*    95.2%     84.1%
   Actual compliance†    73.4%     84.1%
3-4 weeks (N=252)
 Complete (case) 237 198
 Incomplete (case) 15  54
   Reported compliance    94.4%     78.6%
   Actual compliance    67.2%     78.6%
* Response rate of the case report forms reported to be completed 
by the study subjects
† Response rate of the case report forms actually completed by the 
study subjects
Table 8. The difference between reported compliance and 
actual compliance
Control Intervention
No. of input errors 78 (2.3%)
Total case: 3,331
52 (1.8%)
Total case: 2,832
No. of subjects that enter 
  wrong data
11 (61.1%)
Total subjects: 18
14 (77.8%)
Total subjects: 18
Input error per a subject 7 4
Table 7. The profile of input errors
Variables Response
Group N (%)
χ2 p
Control (N=3,409) Intervention (N=2,894)
Sex Male Yes 1,577 (96.6) 1,811 (98.9)  63.42 0.0001
No   55 ( 3.4)   19 ( 1.1)
Female Yes 1,832 (94.5) 1,083 (99.2)
No   106 ( 5.5)    9 ( 0.8)
Age Below 40 Yes   548 (97.2) 2,084 (98.9) 38.24 0.0001
No    16 ( 2.8)   22 ( 1.1)
Over 40 Yes 2,861 (95.2)  810 (99.3)
No   145 ( 4.8)    6 ( 0.7)
Disease
 duration
Less than 2 years Yes 1,929 (96.5) 1,317 (99.3) 77.36 0.0001
No   69 ( 3.5)   9 ( 0.7)
More than 2 years Yes 1,480 (94.2) 1,577 (98.8)
No   92 ( 5.8)   19 ( 1.2)
Table 6. Mantel-Haenszel test of response completeness controlling sex, age, and disease duration
Female has higher completeness than male in the con-
trol group while male has higher completeness in the 
intervention group (63.42, p=0.0001). In addition, over 
40 group has better completeness in the control group 
while below 40s has better completeness in the PDA 
group (38.24, p=0.0001). Below 40s Male rather than 
over 40s female, whose disease duration is over 2 yrs, 
fells comfortable to enter clinical study data with PDAs 
(77.36, p=0.001) (Table 6). This result shows Sex, Age 
and disease duration has significant relationship with the 
use of PDA for data collection.
4. Input error
In the control group, 11 subjects committed 78 cases 
of input error, whereas in the intervention group, 14 
subjects committed 52 cases of input error. Additio-
nally, the characteristics of the errors were different 
across the two groups. The major errors in the control 
group were duplicate answers in a question. By con-
trast, the errors in the intervention group were func-
tional errors, like pushing the wrong button or the same 
button twice causing unwanted double entry in a day. 
As subjects become proficient with the PDA, errors are 
expected to decrease. Nonetheless, the input error per 
person for the PDA group (4 cases) was lower than that 
for the paper group (7 cases) (Table 7). 
5. Protocol compliance
Protocol compliance means that both groups should 
enter their medication intakes during five weeks at five 
measurement periods on a paper or a PDA form. 95.2% 
of the control group reported that they answered the 
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questionnaires according to the direction during first 
through second weeks, however, only 73.4% followed 
up the direction correctly. On the other hand, since 
PDA group transmit data as soon as items are an-
swered, reported and actual response rate are identical 
as 84.1%. The compliance rate for 1-2 weeks of the 
intervention group is higher than the control group 
(Table 8). 
In third through fourth weeks, 94.4% of the control 
group reported to follow up the diction, however only 
67.2 % actually answered correctly, Thus, the protocol 
compliance rate for 3-4 weeks of the intervention group 
is also higher than the control group as 78.6% (Table 
8).
IV. Discussion
This study addresses whether wireless PDA tech-
nology can reduce clinical data input error and improve 
response rate, data quality and protocol compliance. 
Average age choosing PDA group is much lower 
than non-PDA group. Higher preference for PDA of 
younger generation is likely due to their equal fami-
liarity with mobile phone. As mobile phones continue to 
become integrated into their daily lives, mobile EDC 
preference among patients may continue to grow. 
In spite of participants’ preference, the response rate 
was lower than paper group. We assume that current 
PDA technology is not stable and reliable to use for 
clinical trials yet based on our supplementary survey. 
The survey regarding the PDA usage shows that few 
users become disgruntled and complained some diffi-
culties of PDA data entry. Out of 21 respondents, 66% 
of them showed the difficulty of PDA usages, and 33% 
had unstable internet access. To apply PDA for clinical 
data collection, these technical issues should be resolved 
soon. 
Our finding also supports previous literature reporting 
that PDA can enhance completeness of data collec-
tion21). Lower number of the missed items was found in 
the PDA collection compared with paper method. This 
increased data collection has a direct beneficial impact 
on the quality of data collected.
Regarding to input errors, PDA is supposed to have 
error free data collection compared with paper. How-
ever, PDA collection still has input errors. The errors 
were functional errors, like pushing the wrong button or 
the same button twice. Therefore, predesigned functions 
alerting users before developing e-CRF application will 
be able to reduce possible errors. Electronic data entry 
will not result in error-free data collection without built 
in check functions. Minimizing the data entry errors that 
result from extra data entry steps will streamline the 
data clean-up stage of clinical trials. 
In spite of few errors, the quality of data in PDA is 
improved in comparison to paper group because the 
data are more complete, have fewer errors, and there 
are fewer protocol violations like other studies14)22-24). 
Thus, data editing, retyping, proofreading, and the pro-
cess of clarification can be eliminated, and irrelevant 
questions can be omitted.
Also, protocol compliance was comparably improved. 
Significant retrospective entries were made in the con-
trol group. Poor diary completion may result from having 
unreasonable expectations of patients and giving incom-
plete instructions. Electronic, time coded diaries could 
ensure better quality of records.
Selection bias can occur because the intervention 
group is self-selected according to their preference. In 
addition, recruitment only included patients treated by 
an investigator in large hospital. This sampling method 
limits the degree of generalization of our results and 
may not reflect outcomes in other setting. Additional 
attempt to control potential impact of selection bias 
should be made in this type of research. Also, this 
study should be replicated using a larger number of 
subjects from various clinical trial studies in future.
This study shows advantages and some weakness of 
wireless PDA technology applying for clinical trials. 
Our results showed input errors are significantly re-
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duced but PDA based data collection cannot improve 
response rate. PDAs with wireless internet capabilities 
have the potential to improve clinical trial data collec-
tion and management, and thus, to expedite the deve-
lopment of important new drugs. In spite of various 
overseas researches in the area of electronic diary, PDA 
has not been used in clinical trial yet in Korea. 
However, wide adoption of PDA technology is expected 
with better designed PDA hardware and software appli-
cations, faster internet access, improved battery life, 
seamless integration of PDA technology with hospital 
information systems, and satisfactory security measures. 
Herein, we described some barriers and benefits based 
on our experience to collect clinical trial data. We de-
sire it will give you some idea on how to successfully 
implement PDA based data capture system in your 
organization. The results of this study confirm the feasi-
bility and adaptability of the data capture through PDA 
administered questionnaires. Analysis of data comple-
teness, response rate, and protocol compliance suggest 
that the IBS questionnaires can be maintained under 
PDA application. 
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